CRYO CELL INTERNATIONAL INC

Cryopreserves newborn cord blood and tissue stem cells for expectant families.

CCEL | NYSE

Overview

Corporate Details

ISIN(s):: US2288951088
LEI:
Country:: United States of America
Address:: 700 BROOKER CREEK BLVD, 34677 OLDSMAR
Website:: https://www.cryo-cell.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Cryo-Cell International, Inc., established in 1989, is the world's first private cord blood bank. The company provides premier cryopreservation services for umbilical cord blood and cord tissue stem cells. Its core business involves the collection, processing, and long-term cryogenic storage of these cells for exclusive family use. These stem cells can be used to treat numerous diseases and conditions, with ongoing research expanding their potential applications in regenerative medicine. Trusted by over 500,000 parents globally, Cryo-Cell utilizes advanced processing technologies and a proprietary five-chamber storage bag to ensure the long-term viability and multiple treatment opportunities from a single collection. The company's target market consists of expectant families seeking to preserve their newborn's stem cells for future health needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CRYO CELL INTERNATIONAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CRYO CELL INTERNATIONAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CRYO CELL INTERNATIONAL INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ORGANOIDSCIENCES LTD. Organoid-based platforms for drug testing and regenerative therapeutics.	South Korea	476040
Oricon Inc. Provides entertainment industry data, music charts, web media, and marketing services.	Japan	4800
ORIENTBIO Inc. Provides animal models & technical services for preclinical R&D to pharma & research institutions.	South Korea	002630
Oryzon Genomics S.A. Develops epigenetic-based medicines for cancer and central nervous system disorders.	Spain	ORY
OSCOTECInc. A clinical-stage drug discovery company developing innovative medicines for unmet needs.	South Korea	039200
OSE Immunotherapeutics Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.	France	OSE
Oxurion NV Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.	Belgium	OXUR
PA Co., Ltd Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.	Japan	4766
Passage BIO, Inc. Developing genetic medicines for severe CNS and neurodegenerative disorders.	United States of America	PASG
PCI Biotech Holding Biopharma firm evaluating its future after discontinuing its core technology development.	Norway	PCIB